本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioLine Rx

3.31
-0.1000-2.93%
成交量:6,492.00
成交額:2.18萬
市值:1,231.65萬
市盈率:-0.72
高:3.40
開:3.40
低:3.30
收:3.41
資料載入中...
2025/03/31

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/26

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/03/26

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/27

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/03/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/20

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/09

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/16

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/26

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/23

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/23

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/20

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/19

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses